Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Wednesday, September 13th. I hope you have a great day in the market. Now, let's get ready to trade! Markets ð Stocks stumbled on Tuesday after a strong start to the week. The Nasdaq sold off for a 1.0% loss, while the S&P 500 lost half a point. The Dow closed with a small loss of less than 0.1%, and the Russell 2K ended the day flat. Futures are down again in early trading. S&P 500 contracts have declined 0.1% ahead of today's open. Sponsored [Forget 99% of the Stock Market ð¯]( Hi folks, Jeff Clark here... I've made my money by IGNORING 99% of the entire stock market. And I can't sit around anymore, watching people get slaughtered in the markets. I've helped my readers double their money 13 TIMES in the last year alone. All by ignoring 99% of the market and focusing on only ONE stock. I call it, "The One-Stock Retirement." [Click here to watch this "Financial Intervention."]( Premarket Highlights ð ð Arm Prepares for Massive IPO British chip designed Arm Holdings is set to price its highly-anticipated IPO later today. Analyst estimates say it could debut a or above $51 per share, denoting a valuation of more than $52 billion. It's expected to be the biggest IPO of 2023, ending a long drought of notable public offerings. What to Watch Today ð August CPI New inflation numbers will drop at 8:30 a.m. today, and the market will be listening closely. We're beginning to see early signals that the labor market is softening, so we could be nearing the end of the Fed's rate hike cycle if inflation continues to slow down. Last month, the U.S. economy experienced a small uptick in inflation, so it will be even more crucial that market watchers see progress in August's CPI data. Median forecasts are calling for CPI to increase 3.6% annually and 0.6% from last month. Major Earnings ð° Cracker Barrel Old Country Store, Inc. [CBRL] ... AM
Rev Group, Inc.[REVG] ... AM
Selectquote, Inc. [SLQT] ... AM
Coda Octopus Group, Inc. [CODA] ... AM
Semtech Corporation [SMTC] ... PM
IBEX Limited [IBEX] ... PM
Radiant Logistics, Inc. [RLGT] ... PM
Research Solutions, Inc [RSSS] ... PM
Streamline Health Solutions, Inc. [STRM] ... PM
Ocean Power Technologies, Inc. [OPTT] ... PM Economy ð - Consumer price index [Aug] ... 8:30a
- Core CPI [Aug] ... 8:30a Running Hot ð¥ Gainers
- Chicken Soup for the Soul [CSSE] >> +21.6%
- HHL Acquisition [HHLA] >> +26.8%
- Sentage Holdings [SNTG] >> +21.9%
- Digital Media Solutions [DMS] >> +18.7% Decliners
- Spectral AI [MDAI] >> (58.6%)
- KULR Technology Group (28.1%) >> (33.5%)
- Eiger Biopharma [EIGR] >> (36.2%)
- Nature Wood [NWGL] >> (16.5%) Moderna [MRNA] - Last Close: $105.24 Moderna is rallying after a regulatory decision. On Tuesday, the CDC recommended a new COVID-19 booster for Americans older than 6 months of age. Moderna expects to generate sales as high as $8 billion from its COVID-19 treatments in 2023, according to internal company estimates. Also, this morning, billionaire investor Ron Baron announced he had opened a "very small investment" in Moderna. MRNA is leading the S&P 500 with a 4.3% gain. My Take: MRNA has underperformed over the past 12 months. I think it's going to take more than a COVID-19 booster to put this company back on an upward trajectory. Rocket Pharmaceuticals [RCKT] - Last Close: $15.29 Rocket Pharma is trending after a drug breakthrough. Late Tuesday, the company said it has reached an agreement with the FDA on the design of a pivotal Phase 2 trial for RP-A501 in Danon disease patients. Rocket and the FDA set two key endpoints for the upcoming trial, and Rocket said it expects to complete filings to enable EU study activities sometime this year. Hours later, the company also announced a $175 million upsized public offering of its common stock. RCKT is up 23.0% in early premarket trading. My Take: I like this chart. RCKT could be positioned for a swing higher, and it has an elevated short ratio that could provide a nice setup for a short squeeze, if the conditions are just right. Mainz Biomed [MYNZ] - Last Close: $3.66 Positive drug data is boosting shares of Mainz Biomed. Early this morning, the tiny biotech announced a clinical study assessing novel mRNA biomarkers for colorectal cancer testing showed "positive" results. Mainz Bio said the top-line results from its ColoFuture study detected colorectal cancer with 94% sensitivity and 97% specificity. The results bode well for Mainz efforts to commercialize its colon cancer screening test across Europe and other "select international territories." MYNZ is trading actively in the premarket with a 13.9% gain. My Take: MYNZ is coming off a double bottom-ish move that could signal an upcoming swing in this stock's fortunes. The momentum from this announcement could mark the beginning of a pivot towards an up-trend. Avalo Therapeutics [AVTX] - Last Close: $0.1235 No, it's not a mistake. Avalo Therapeutics is on our list for the second day in a row. The tiny biotech stock jumped 45% on Tuesday after announcing a deal to sell several of its drug candidates for cash and potential milestone payments. Altogether, the deal could generate $45 million for Avalo if all the contingent payment conditions are satisfied. AVTX continued to rally after Tuesday's closing bell, and it's exploding again in today's premarket with no additional company news. AVTX is on pace to outperform its Tuesday rally with an 83.7% premarket gain, and it's this morning's number-one premarket stock. My Take: I am still doubtful about the long-term viability of this rally. If you cashed in on this trade, you might want to consider taking some profits off the table before the inevitable reversal finally materializes. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.
[Bots click here]( 1969 S. ALAFAYA TRAIL
Orlando FL 32828
USA [Unsubscribe]( | [Change Subscriber Options](